Cardiovascular disease and mental illness commonly co-occur. Addressing them together can improve both mental health and ...

An analysis of pooled data from two large finerenone trials identified key risk factors for hyperkalemia in patients with CKD ...

The large molecule drug substance CDMO market is anticipated to expand at a CAGR of ~9% during the forecast period. Key ...

Targeting PDE4 drives anti-inflammatory and antifibrotic effects, and Boehringer has been working on its own PDE4 inhibitor ...

The newly formed advisory board, which held its inaugural meeting last month, will identify opportunities to enhance scientific capabilities to ensure that OXB remains at the forefront of developing ...

The large molecule injectable drugs market is anticipated to expand at a CAGR of ~9% during the forecast period. Key drivers ...

Nerandomilast slowed lung function decline in people with IPF and PPF after a year of treatment, according to data from two ...

With a market cap of $681.8 billion, Eli Lilly and Company (LLY) is a leading global pharmaceutical company focused on ...

The Boehringer Ingelheim booth is seen at the fourth China International Import Expo in Shanghai in November. [Provided to China Daily] German multinational pharmaceutical company Boehringer Ingelheim ...

The global veterinary dermatology market, valued at US$18.59 billion in 2024, is forecasted to grow at a robust CAGR of 8.5%, ...

Results presented at this year’s American Thoracic Society International Conference showed that the trials met their primary ...

The payments have raised concerns that doctors could be influenced to favour specific drugs or prescribe them over talking ...